Pseudoginsenoside F11
CAT:
804-HY-N0541-03
Size:
10 mg
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No

Pseudoginsenoside F11
- CAS Number: 69884-00-0
- UNSPSC Description: Pseudoginsenoside F11 (Ginsenoside A1), a component of Panax quinquefolium (American ginseng), has been demonstrated to antagonize the learning and memory deficits induced by scopolamine, morphine and methamphetamine in mice.
- Target Antigen: Endogenous Metabolite
- Type: Natural Products
- Related Pathways: Metabolic Enzyme/Protease
- Field of Research: Others
- Assay Protocol: https://www.medchemexpress.com/Pseudoginsenoside-F11.html
- Purity: 99.87
- Solubility: DMSO : 50 mg/mL (ultrasonic;warming;heat to 60°C)|H2O : 0.67 mg/mL (ultrasonic)
- Smiles: C[C@@]([C@@]12C)(C[C@H](O[C@@](O[C@H](CO)[C@@H](O)[C@@H]3O)([H])[C@@H]3O[C@@](O[C@@H](C)[C@H](O)[C@H]4O)([H])[C@@H]4O)[C@@]5([H])C6(C)C)[C@@](C[C@@H](O)[C@]1([H])[C@]([C@]7(O[C@@H](C(C)(O)C)CC7)C)([H])CC2)([H])[C@]5(CC[C@@H]6O)C
- Molecular Weight: 801.01
- References & Citations: [1]Wang H, et al. The pseudoginsenoside F11 ameliorates cisplatin-induced nephrotoxicity without compromising its anti-tumor activity in vivo. Scientific Reports [2014, 4:4986]|[2]Li Zhu, et al. Pseudoginsenoside-F11 attenuates morphine-induced signalling in Chinese hamster ovary-μ cells. Neuroreport, 25 May 2001 - Volume 12 - Issue 7 - pp 1453-1456|[3]Yue Hao, et al. Pseudoginsenoside-F11 decreases morphine-induced behavioral sensitization and extracellular glutamate levels in the medial prefrontal cortex in mice. Pharmacology Biochemistry and Behavior
 Volume 86, Issue 4, April 2007, Pages 660–666
- Shipping Conditions: Room Temperature
- Storage Conditions: 4°C (Powder, sealed storage, away from moisture and light)
- Clinical Information: No Development Reported